The Moderna Vaccine IndexThese companies are selected for composition "Moderna Vaccine" because
1.developed the vaccine
2.suppliers
3.distribution chain
Weights are calculated by relative market cap.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.78 USD
141.70 M USD
790.65 M USD
18.47 M
About Laboratorios Farmaceuticos Rovi, S.A.
Sector
Industry
CEO
Juan López-Belmonte Encina
Website
Headquarters
Madrid
Founded
1946
ISIN
ES0157261019
FIGI
BBG00YD8S1S0
Laboratorios Farmaceúticos Rovi SA engages in the research, development, manufacture, and marketing of small molecule and specialty biologic drugs. It operates through the following business segments: Manufacturing, Marketing, and Other. The Manufacturing segment obtains its income from service contracts that relate to the finalization of the pharmaceutical product production process for external entities and the manufacture of products to be subsequently marketed by other group companies. The Marketing segment purchases and sells pharmaceutical products. The Other segment includes other services, research, and development activities that are not significant for the group. The company was founded on December 21, 1946 and is headquartered in Madrid, Spain.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
EMUSC.EUR
UBS (Lux) Fund Solutions SICAV - UBS MSCI EMU Small Cap UCITS ETF EUR acc- CapitalisationWeight
0.22%
Market value
1.56 M
USD
EMUSCD.EUR
UBS (Lux) Fund Solutions SICAV - UBS MSCI EMU Small Cap UCITS ETF EUR Ukdis- DistributionWeight
0.22%
Market value
1.56 M
USD
UEFD
UBS (Lux) Fund Solutions SICAV - UBS MSCI EMU Small Cap UCITS ETF EUR dis- DistributionWeight
0.22%
Market value
1.56 M
USD
Explore more ETFs
Frequently Asked Questions
The current price of LABFF is 65.86 USD — it has decreased by −27.31% in the past 24 hours. Watch LABORATORIOS FARMACEUTICOS ROVI SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange LABORATORIOS FARMACEUTICOS ROVI SA stocks are traded under the ticker LABFF.
We've gathered analysts' opinions on LABORATORIOS FARMACEUTICOS ROVI SA future price: according to them, LABFF price has a max estimate of 106.31 USD and a min estimate of 80.89 USD. Watch LABFF chart and read a more detailed LABORATORIOS FARMACEUTICOS ROVI SA stock forecast: see what analysts think of LABORATORIOS FARMACEUTICOS ROVI SA and suggest that you do with its stocks.
LABFF reached its all-time high on Jul 1, 2024 with the price of 90.61 USD, and its all-time low was 0.03 USD and was reached on Apr 25, 2022. View more price dynamics on LABFF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LABFF stock is 37.57% volatile and has beta coefficient of 0.63. Track LABORATORIOS FARMACEUTICOS ROVI SA stock price on the chart and check out the list of the most volatile stocks — is LABORATORIOS FARMACEUTICOS ROVI SA there?
Today LABORATORIOS FARMACEUTICOS ROVI SA has the market capitalization of 3.56 B, it has decreased by −0.42% over the last week.
Yes, you can track LABORATORIOS FARMACEUTICOS ROVI SA financials in yearly and quarterly reports right on TradingView.
LABORATORIOS FARMACEUTICOS ROVI SA is going to release the next earnings report on Mar 3, 2026. Keep track of upcoming events with our Earnings Calendar.
LABFF net income for the last quarter is 68.09 M USD, while the quarter before that showed 25.49 M USD of net income which accounts for 167.18% change. Track more LABORATORIOS FARMACEUTICOS ROVI SA financial stats to get the full picture.
Yes, LABFF dividends are paid annually. The last dividend per share was 0.88 USD. As of today, Dividend Yield (TTM)% is 1.27%. Tracking LABORATORIOS FARMACEUTICOS ROVI SA dividends might help you take more informed decisions.
LABORATORIOS FARMACEUTICOS ROVI SA dividend yield was 1.20% in 2024, and payout ratio reached 28.30%. The year before the numbers were 1.49% and 27.20% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 8, 2025, the company has 2.2 K employees. See our rating of the largest employees — is LABORATORIOS FARMACEUTICOS ROVI SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LABORATORIOS FARMACEUTICOS ROVI SA EBITDA is 211.49 M USD, and current EBITDA margin is 27.07%. See more stats in LABORATORIOS FARMACEUTICOS ROVI SA financial statements.
Like other stocks, LABFF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LABORATORIOS FARMACEUTICOS ROVI SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LABORATORIOS FARMACEUTICOS ROVI SA technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LABORATORIOS FARMACEUTICOS ROVI SA stock shows the neutral signal. See more of LABORATORIOS FARMACEUTICOS ROVI SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.